Skip to Main Content

Author Details

Colin C Collins
University of British Columbia
1988
214
68
PMIDPaper TitleJournal TitlePublished Year
37831068RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential.Mol Cancer Res2024
37279093A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.Clin Cancer Res2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
37425866RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.bioRxiv2023
37452083Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.Cancer Gene Ther2023
35082166Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.Mol Cancer Res2022
35602596TEAD4 as an Oncogene and a Mitochondrial Modulator.Front Cell Dev Biol2022
35789834Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer.iScience2022
35563856Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.Cells2022
35816165Isolating Nuclei From Frozen Human Heart Tissue for Single-Nucleus RNA Sequencing.Curr Protoc2022
35963852Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.Nat Commun2022
33038264GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.Int J Cancer2021
33568749ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.Prostate Cancer Prostatic Dis2021
33709547Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signaling.EMBO Mol Med2021
34934057The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.Nat Commun2021
33960594Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.Cancer Sci2021
33975627Functional mapping of androgen receptor enhancer activity.Genome Biol2021
33441310Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.Cancer Res2021
32259207CircMiner: accurate and rapid detection of circular RNA through splice-aware pseudo-alignment scheme.Bioinformatics2020
31919137Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.Clin Cancer Res2020
33299664Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.Oncoimmunology2020
33324443Identification of a Transcriptomic Prognostic Signature by Machine Learning Using a Combination of Small Cohorts of Prostate Cancer.Front Genet2020
32657374Identification of conserved evolutionary trajectories in tumors.Bioinformatics2020
32657371AITL: Adversarial Inductive Transfer Learning with input and output space adaptation for pharmacogenomics.Bioinformatics2020
32847979Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.Mol Cancer Ther2020
32512818Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.Cells2020
30274982Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.Clin Cancer Res2019
31454437Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men.Prostate2019
31510700MOLI: multi-omics late integration with deep neural networks for drug response prediction.Bioinformatics2019
31445843The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.Eur Urol2019
30777011Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer.BMC Genomics2019
30776192The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.Mol Oncol2019
31125117Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.Int J Cancer2019
31064850Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer.Cancer Res2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30978274Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.Gigascience2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
30910347RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.Eur Urol2019
30351359Alignment-free clustering of UMI tagged DNA molecules.Bioinformatics2019
30590461Modeling human prostate cancer progression in vitro.Carcinogenesis2019
30636931Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.Cancer Cell Int2019
28927585Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol2018
30022998Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.Front Genet2018
29905005Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.Cancer Med2018
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
29617966MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactions.Bioinformatics2018
29441566Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.Int J Cancer2018
29381682Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.Br J Cancer2018
29544736Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.Eur Urol2018
29487201Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res2018
  • 1 - 50 of 214

Recommended Authors

Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 15
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 51
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 31
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 9
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 10
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 46
Joachim Weischenfeldt
University of Copenhagen
Career Start Year 2004
Number of shared co-authors 28
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 19
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 20
Erich Jaeger
Illumina Inc.
Career Start Year 2001
Number of shared co-authors 4
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 20
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 3
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 53
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 6
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 19
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 19
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 33
Alexei Protopopov
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 9
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 25
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 11
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 5
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 16
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 29
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 18
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 35
Jeremy Clark
Norwich Medical School, University of East Anglia
Career Start Year 1989
Number of shared co-authors 17
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 12
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 45
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 22

Collaborators

Yuzhuo Wang
University of British Columbia
Co-authored papers 61
Martin E Gleave
University of British Columbia
Co-authored papers 47
Stanislav V Volik
University of British Columbia
Co-authored papers 41
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 35
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 34
Joe W Gray
Oregon Health and Science University
Co-authored papers 30
Alexander W Wyatt
University of British Columbia
Co-authored papers 29
Anne Haegert
University of British Columbia
Co-authored papers 24
Ladan Fazli
University of British Columbia
Co-authored papers 23
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers 23
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 21
Robert H Bell
University of British Columbia
Co-authored papers 19
Mark A Rubin
University of Bern
Co-authored papers 17
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers 16
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 13
Faraz Hach
University of British Columbia
Co-authored papers 12
Shawn Anderson
University of British Columbia
Co-authored papers 12
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 12
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 12
Amina Zoubeidi
University of British Columbia
Co-authored papers 11
Brian McConeghy
University of British Columbia
Co-authored papers 11
Varune R Ramnarine
University of British Columbia
Co-authored papers 10
Elai Davicioni
Veracyte Inc.
Co-authored papers 10
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 10
Paul C Boutros
University of California los angeles
Co-authored papers 10
Michael R Hayden
Co-authored papers 10
Chunxiao Wu
Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 9
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Robert G Bristow
University of Toronto
Co-authored papers 9
Andrew McPherson
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Release 1.2